Characterization of two different cytoplasmic protein tyrosine kinases from human breast cancer

被引:8
|
作者
Chedin, M
Filhol, O
Duminy, C
Bolla, M
Benistant, C
Roche, S
Chambaz, EM
Cochet, C
机构
[1] CEA, DBMS,INSERM,U244, LAB BIOCHIM REGULAT CELLULAIRES ENDOCRINES, F-38054 GRENOBLE 9, FRANCE
[2] CHU GRENOBLE, UNITE CONCERTAT CANCEROL, F-38043 GRENOBLE 9, FRANCE
[3] FAC PHARM MONTPELLIER, CJF 9207, F-34033 MONTPELLIER, FRANCE
关键词
D O I
10.1093/carcin/18.8.1463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two different protein tyrosine kinases were detected in the cytosolic fraction of different human tumor tissues, After partial purification, the two enzymes, which were highly active in breast tumor tissues, were characterized, One of them, soluble tyrosine kinase-l (STK-1), represents a soluble form of the c-Src protein, which is apparently underphosphorylated on its C-terminal tyrosine residue whereas the other (STK-2) is a 48-kDa protein tyrosine kinase (PTK), which is molecularly and functionally related to the C-terminal Src kinase (Csk), These two protein tyrosine kinases clearly exhibit a different substrate specificity, and are responsible for the high tyrosine kinase activity present in the cytosolic fraction of human breast cancer, In addition, it was observed that STK-1 and STK-2 are also expressed in the breast cancer cell line, CAL-51.
引用
收藏
页码:1463 / 1472
页数:10
相关论文
共 50 条
  • [31] Identification and characterization of Src protein tyrosine kinases in cardiac mitochondria
    Baines, CP
    Ping, PP
    CIRCULATION, 2003, 108 (17) : 273 - 274
  • [32] A CONSERVED NONENZYMATIC DOMAIN IN CYTOPLASMIC PROTEIN-TYROSINE KINASES IS IMPORTANT FOR TRANSFORMING ACTIVITY
    SADOWSKI, I
    PAWSON, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 156 - 156
  • [33] Protein tyrosine phosphatases and breast cancer
    Freiss, G
    Vignon, F
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 9 - 17
  • [34] Type 1 protein tyrosine kinases in benign and malignant breast lesions
    Suo, Z
    Emilsen, E
    Tveit, KM
    Nesland, JM
    HISTOPATHOLOGY, 1998, 33 (06) : 514 - 521
  • [35] CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases
    Zahnow, Cynthia A.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
  • [36] The use of protein array to identify targetable receptor tyrosine kinases for treatment of human colon cancer
    Morishita, Asahiro
    Gong, Jian
    Nomura, Takako
    Yoshida, Hirohito
    Izuishi, Kunihiko
    Suzuki, Yasuyuki
    Kushida, Yoshio
    Haba, Reiji
    D'Armientoi, Jeanine
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (04) : 829 - 835
  • [38] The ErbB/HER receptor protein-tyrosine kinases and cancer
    Roskoski, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (01) : 1 - 11
  • [39] Proteomic Characterization of Cytoplasmic Lipid Droplets in Human Metastatic Breast Cancer Cells
    Zembroski, Alyssa S.
    Andolino, Chaylen
    Buhman, Kimberly K.
    Teegarden, Dorothy
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Proteomic characterization of cytoplasmic lipid droplets in human metastatic breast cancer cells
    Zembroski, Alyssa S.
    Andolino, Chaylen
    Buhman, Kimberly K.
    Teegarden, Dorothy
    CANCER RESEARCH, 2020, 80 (16)